Understanding the Stakes: Lung Cancer and the PD-L1 Challenge Lung cancer is the most diagnosed cancer worldwide, with nearly two million new cases reported each year. Among its types, non-small cell lung cancer (NSCLC) dominates […]
A Fresh Approach to Treating Diffuse Large B-Cell Lymphoma (DLBCL) Diffuse large B-cell lymphoma (DLBCL) is the most common and aggressive type of non-Hodgkin lymphoma (NHL), a group of cancers that affect the lymphatic system. […]
Could CRELD2 Be a Key Biomarker in Triple-Negative Breast Cancer? A new study from researchers at Necmettin Erbakan University suggests that a specific protein, CRELD2, might help predict outcomes for patients with triple-negative breast cancer […]
Peer review is crucial in the scientific publishing process, as it ensures that research papers meet high-quality and accurate standards. Each month, the BiomolBiomed Editorial team recognizes a reviewer who has delivered outstanding and constructive […]
Lung cancer is the leading cause of cancer-related deaths globally, with nearly 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) accounts for approximately 80%–85% of all lung cancer cases. Most patients are diagnosed […]
For the past four decades, the 67 kDa laminin receptor (67LR) has been a central focus of cancer research, especially in the study of colorectal carcinoma. This receptor was hypothesized to consist of a complex […]
Low-grade glioma (LGG) belongs to a large class of gliomas, tumors that occur in the brain and spinal cord, with great intrinsic heterogeneity. In recent years, in-depth studies of the tumor microenvironment have made a […]
The urokinase plasminogen activator system is an important asset of cancer cells’ pro-metastatic arsenal, as its components coordinate the targeted degradation of the surrounding. Researchers from the Medical University of Plovdiv sought to explore whether […]
Breast cancer is the most common type of cancer in women, aside from skin cancers. Studies have demonstrated that keeping track of cancer treatment can enhance patient results. Due to the absence of a centralized […]
Although considerable advances have been made in the clinical treatment of osteosarcoma (OS), a type of bone cancer, the overall survival rate of OS patients has not significantly increased. In order to expand the choices […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH